CRISPR Therapeutics (CRSP) Shares Dip Amid Anthropic AI Enzyme Discovery, Highlighting Valuation Challenges

On September 23, 2026, shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and other gene editing firms declined following Anthropic's announcement that its AI mode

KabuDo's automated read: this looks like a positive signal for healthcare. Potentially affected tickers include CRSP (US), CRSPN.MX (MX), and 0VRQ.L (GB).